human umbilical cord blood mesenchymal stem cells therapy(Xuanwu Hospital Of Capital Medical University)

N/A

Report date: 2024/09/20 20:00:41

Base Information

Drug Namehuman umbilical cord blood mesenchymal stem cells therapy(Xuanwu Hospital Of Capital Medical University)
Drug Alias NamehUC-MSC-sEV-001
ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsUpdating
Therapy Area/IndicationsAmyotrophic Lateral SclerosisFrontotemporal DementiaAlzheimer Disease +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesXuanwu Hospital Of Capital Medical University
China Registration ClassN/A

Develop Information

Active CompaniesXuanwu Hospital Of Capital Medical University
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisFrontotemporal DementiaAlzheimer Disease +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A